Ocular and orbital side-effects of checkpoint inhibitors: a review article.
2016
Purpose of reviewCheckpoint inhibitors have been increasingly considered as new targets for cancer therapies. Patients receiving checkpoint inhibitors develop many immune-related adverse events (IRAEs). However, ophthalmic IRAEs are rare and have been reported in less than 1% of patients. To date, f
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
75
Citations
NaN
KQI